Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?

It is not standardised what is the endometrial thickness that discriminates between normal and potentially malignant. The objective of this study was to determine the endometrial thickness cut-off point from which the risk of endometrial cancer (EC) increases in asymptomatic postmenopausal women; an...

Full description

Bibliographic Details
Main Authors: Alba María Cruz García, Elena Pérez Morales, Ludmila Ocón Padrón, Cristina Pérez Matos, Alejandra Santana Suárez, Yonit Emergui Zrihen, María Ángeles Nieto Naya, Victoria Sánchez Sánchez, Alicia Martín Martínez
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Obstetrics and Gynaecology
Subjects:
Online Access:http://dx.doi.org/10.1080/01443615.2022.2160928
_version_ 1797685675674304512
author Alba María Cruz García
Elena Pérez Morales
Ludmila Ocón Padrón
Cristina Pérez Matos
Alejandra Santana Suárez
Yonit Emergui Zrihen
María Ángeles Nieto Naya
Victoria Sánchez Sánchez
Alicia Martín Martínez
author_facet Alba María Cruz García
Elena Pérez Morales
Ludmila Ocón Padrón
Cristina Pérez Matos
Alejandra Santana Suárez
Yonit Emergui Zrihen
María Ángeles Nieto Naya
Victoria Sánchez Sánchez
Alicia Martín Martínez
author_sort Alba María Cruz García
collection DOAJ
description It is not standardised what is the endometrial thickness that discriminates between normal and potentially malignant. The objective of this study was to determine the endometrial thickness cut-off point from which the risk of endometrial cancer (EC) increases in asymptomatic postmenopausal women; and to evaluate the risk factors linked to malignant endometrial pathology as well as other associated ultrasound findings. This was a retrospective observational study that included hysteroscopies performed at the Hospital Materno-Infantil on 267 asymptomatic menopausal women with an increase in endometrial thickness (AET) >5 mm, from 2015 to 2019. The results shows that the prevalence of malignant pathology in asymptomatic postmenopausal women with a casual finding of endometrial thickening was 3.7%. This percentage was 16.3% when the cut-off point of AET was established at 10 mm. There was a significant association for the diagnosis of malignant pathology with this cut-off point. There is a significant association between the 10 mm endometrial thickness cut-off point from which the risk of EC increases in asymptomatic postmenopausal women.Impact statement What is already known on this subject? Several studies have established the cut-off point for asymptomatic endometrial thickening (AET) for atypical endometrial hyperplasia and endometrial cancer at 10 mm. Although no cut-off point has optimal accuracy for the diagnosis of malignant endometrial pathology, it has been found that with a cut-off value of AET >10 mm no cases are missed. Likewise, a cut-off point of AET > 11 mm may provide a balance between cancer detection and histopathological workup extension. What do the results of this study add? A significant association was found at the cut-off point of AET > 10 mm, which suggests that screening postmenopausal women at this thickness is acceptable and unlikely to miss cases of endometrial hyperplasia and endometrial cancer. What are the implications of these findings for clinical practice and/or further research? After analysing our results we can conclude, like other published studies, that by establishing a cut-off point of 10 mm we obtain a good discrimination between benign and malignant pathology, which would allow us to diagnose 100% of malignant pathology. Above this cut-off point, the risk of endometrial cancer increases, and it would therefore be advisable to extend the study. A multicentre study is needed to confirm the cut-off point at which the risk of endometrial cancer increases in postmenopausal women with asymptomatic endometrial thickening.
first_indexed 2024-03-12T00:48:37Z
format Article
id doaj.art-bf4b6d718fe64d8b8b84d09731c4b2cf
institution Directory Open Access Journal
issn 0144-3615
1364-6893
language English
last_indexed 2024-03-12T00:48:37Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Obstetrics and Gynaecology
spelling doaj.art-bf4b6d718fe64d8b8b84d09731c4b2cf2023-09-14T15:29:13ZengTaylor & Francis GroupJournal of Obstetrics and Gynaecology0144-36151364-68932023-12-0143110.1080/01443615.2022.21609282160928Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?Alba María Cruz García0Elena Pérez Morales1Ludmila Ocón Padrón2Cristina Pérez Matos3Alejandra Santana Suárez4Yonit Emergui Zrihen5María Ángeles Nieto Naya6Victoria Sánchez Sánchez7Alicia Martín Martínez8Service of Gynaecology and Obstetrics, Complejo Hospitalario Universitario Insular Materno Infantil de CanariasService of Gynaecology and Obstetrics, Complejo Hospitalario Universitario Insular Materno Infantil de CanariasService of Gynaecology and Obstetrics, Complejo Hospitalario Universitario Insular Materno Infantil de CanariasService of Gynaecology and Obstetrics, Complejo Hospitalario Universitario Insular Materno Infantil de CanariasService of Gynaecology and Obstetrics, Complejo Hospitalario Universitario Insular Materno Infantil de CanariasService of Gynaecology and Obstetrics, Complejo Hospitalario Universitario Insular Materno Infantil de CanariasService of Gynaecology and Obstetrics, Complejo Hospitalario Universitario Insular Materno Infantil de CanariasService of Gynaecology and Obstetrics, Complejo Hospitalario Universitario Insular Materno Infantil de CanariasService of Gynaecology and Obstetrics, Complejo Hospitalario Universitario Insular Materno Infantil de CanariasIt is not standardised what is the endometrial thickness that discriminates between normal and potentially malignant. The objective of this study was to determine the endometrial thickness cut-off point from which the risk of endometrial cancer (EC) increases in asymptomatic postmenopausal women; and to evaluate the risk factors linked to malignant endometrial pathology as well as other associated ultrasound findings. This was a retrospective observational study that included hysteroscopies performed at the Hospital Materno-Infantil on 267 asymptomatic menopausal women with an increase in endometrial thickness (AET) >5 mm, from 2015 to 2019. The results shows that the prevalence of malignant pathology in asymptomatic postmenopausal women with a casual finding of endometrial thickening was 3.7%. This percentage was 16.3% when the cut-off point of AET was established at 10 mm. There was a significant association for the diagnosis of malignant pathology with this cut-off point. There is a significant association between the 10 mm endometrial thickness cut-off point from which the risk of EC increases in asymptomatic postmenopausal women.Impact statement What is already known on this subject? Several studies have established the cut-off point for asymptomatic endometrial thickening (AET) for atypical endometrial hyperplasia and endometrial cancer at 10 mm. Although no cut-off point has optimal accuracy for the diagnosis of malignant endometrial pathology, it has been found that with a cut-off value of AET >10 mm no cases are missed. Likewise, a cut-off point of AET > 11 mm may provide a balance between cancer detection and histopathological workup extension. What do the results of this study add? A significant association was found at the cut-off point of AET > 10 mm, which suggests that screening postmenopausal women at this thickness is acceptable and unlikely to miss cases of endometrial hyperplasia and endometrial cancer. What are the implications of these findings for clinical practice and/or further research? After analysing our results we can conclude, like other published studies, that by establishing a cut-off point of 10 mm we obtain a good discrimination between benign and malignant pathology, which would allow us to diagnose 100% of malignant pathology. Above this cut-off point, the risk of endometrial cancer increases, and it would therefore be advisable to extend the study. A multicentre study is needed to confirm the cut-off point at which the risk of endometrial cancer increases in postmenopausal women with asymptomatic endometrial thickening.http://dx.doi.org/10.1080/01443615.2022.2160928endometrial thicknessendometrial cancerhyperplasiahysteroscopypostmenopausal bleedingmalignant pathology
spellingShingle Alba María Cruz García
Elena Pérez Morales
Ludmila Ocón Padrón
Cristina Pérez Matos
Alejandra Santana Suárez
Yonit Emergui Zrihen
María Ángeles Nieto Naya
Victoria Sánchez Sánchez
Alicia Martín Martínez
Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?
Journal of Obstetrics and Gynaecology
endometrial thickness
endometrial cancer
hyperplasia
hysteroscopy
postmenopausal bleeding
malignant pathology
title Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?
title_full Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?
title_fullStr Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?
title_full_unstemmed Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?
title_short Asymptomatic endometrial thickening in postmenopausal women: predictor of malignant pathology?
title_sort asymptomatic endometrial thickening in postmenopausal women predictor of malignant pathology
topic endometrial thickness
endometrial cancer
hyperplasia
hysteroscopy
postmenopausal bleeding
malignant pathology
url http://dx.doi.org/10.1080/01443615.2022.2160928
work_keys_str_mv AT albamariacruzgarcia asymptomaticendometrialthickeninginpostmenopausalwomenpredictorofmalignantpathology
AT elenaperezmorales asymptomaticendometrialthickeninginpostmenopausalwomenpredictorofmalignantpathology
AT ludmilaoconpadron asymptomaticendometrialthickeninginpostmenopausalwomenpredictorofmalignantpathology
AT cristinaperezmatos asymptomaticendometrialthickeninginpostmenopausalwomenpredictorofmalignantpathology
AT alejandrasantanasuarez asymptomaticendometrialthickeninginpostmenopausalwomenpredictorofmalignantpathology
AT yonitemerguizrihen asymptomaticendometrialthickeninginpostmenopausalwomenpredictorofmalignantpathology
AT mariaangelesnietonaya asymptomaticendometrialthickeninginpostmenopausalwomenpredictorofmalignantpathology
AT victoriasanchezsanchez asymptomaticendometrialthickeninginpostmenopausalwomenpredictorofmalignantpathology
AT aliciamartinmartinez asymptomaticendometrialthickeninginpostmenopausalwomenpredictorofmalignantpathology